Stock 600436 ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Zhangzhou Pientzehuang Pharmaceutical., Ltd

Equities

600436

CNE000001F21

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 07/05/2024 BST 		5-day change 1st Jan Change
240.2 CNY -1.13% Intraday chart for Zhangzhou Pientzehuang Pharmaceutical., Ltd +1.26% -0.72%
04-19 Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02-02 Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. Signs Cooperation Agreement with Beijing Tong Ren Tang Group CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. Signs Cooperation Agreement with Beijing Tong Ren Tang Group
CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Pientzehuang Logs Slowest Profit Growth in 12 Years
MT
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Pien Tze Huang Pharma’s Q3 Profit Falls 18% as Revenue Slips 3%
MT
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
Market Chatter: Century-Old Chinese Companies Tap Into Stock Market to Fuel Growth
MT
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year Ended June 30, 2021
CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
Exclusive: Sinopharm-led consortium plans $3.3 billion take-private of HK-listed China TCM - sources
RE
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020
CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year Ended June 30, 2020
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 600436 Stock
  4. News Zhangzhou Pientzehuang Pharmaceutical., Ltd
  5. Highlights